• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts.

作者信息

Tauziède-Espariat A, Debily M-A, Castel D, Grill J, Puget S, Roux A, Saffroy R, Pagès M, Gareton A, Chrétien F, Lechapt E, Dangouloff-Ros V, Boddaert N, Varlet P

机构信息

Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 75014, Paris, France.

U981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.

出版信息

Acta Neuropathol Commun. 2020 Jul 9;8(1):104. doi: 10.1186/s40478-020-00974-x.

DOI:10.1186/s40478-020-00974-x
PMID:32646492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7346460/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/7346460/36b437cec5e7/40478_2020_974_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/7346460/e744b0545c9e/40478_2020_974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/7346460/52e8581ae256/40478_2020_974_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/7346460/36b437cec5e7/40478_2020_974_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/7346460/e744b0545c9e/40478_2020_974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/7346460/52e8581ae256/40478_2020_974_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/7346460/36b437cec5e7/40478_2020_974_Fig3_HTML.jpg

相似文献

1
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts.小儿幕上MYCN扩增的高级别胶质瘤甲基化类型与其脑桥对应物具有相同的放射学、组织病理学和分子特征。
Acta Neuropathol Commun. 2020 Jul 9;8(1):104. doi: 10.1186/s40478-020-00974-x.
2
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).小儿脑桥组蛋白野生型伴MYCN扩增的胶质瘤（HGG-MYCN）的综合放射学、组织病理学和分子分析
Acta Neuropathol Commun. 2019 Jun 10;7(1):87. doi: 10.1186/s40478-019-0738-y.
3
Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.全基因组分析揭示了儿童高级别胶质瘤和弥漫性内在脑桥胶质瘤中 ADAM3A 的纯合缺失。
Neuro Oncol. 2011 Feb;13(2):212-22. doi: 10.1093/neuonc/noq158. Epub 2010 Dec 7.
4
Molecular landscape of pediatric diffuse intrinsic pontine gliomas: about 22 cases.小儿弥漫性脑桥内在型胶质瘤的分子图谱：约22例病例
J Neurooncol. 2017 Sep;134(2):465-467. doi: 10.1007/s11060-017-2523-8. Epub 2017 Jun 6.
5
Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.室管膜瘤和儿童弥漫性胶质瘤的分子遗传学：简短综述
Brain Tumor Pathol. 2014 Oct;31(4):229-33. doi: 10.1007/s10014-014-0200-6. Epub 2014 Sep 3.
6
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.患有李-佛美尼综合征的儿科患者中伴有H3F3A G34R突变或MYCN扩增的恶性胶质瘤。
Acta Neuropathol. 2021 Sep;142(3):591-593. doi: 10.1007/s00401-021-02346-8. Epub 2021 Jul 15.
7
The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling.miR-139-5p 通过靶向 PI3K/AKT/mTORC1 信号通路调节幕上儿童低级别胶质瘤的增殖。
Neuropathol Appl Neurobiol. 2018 Dec;44(7):687-706. doi: 10.1111/nan.12479. Epub 2018 Mar 25.
8
A 4-Year-Old Girl With a Supratentorial Mass.一名患有幕上肿块的4岁女童。
Brain Pathol. 2020 Mar;30(2):421-422. doi: 10.1111/bpa.12821.
9
Pediatric supratentorial high-grade gliomas.
Neurosurg Focus. 2003 Feb 15;14(2):e1. doi: 10.3171/foc.2003.14.2.2.
10
Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.小脑高级别胶质瘤不存在与幕上高级别胶质瘤相同的分子改变，且可能显示组蛋白H3基因突变。
Clin Neuropathol. 2018 Sep/Oct;37(5):209-216. doi: 10.5414/NP301104.

引用本文的文献

1
Illuminating radiogenomic signatures in pediatric-type diffuse gliomas: insights into molecular, clinical, and imaging correlations. Part I: high-grade group.小儿型弥漫性胶质瘤中具有启发性的放射基因组特征：分子、临床和影像相关性洞察。第一部分：高级别组。
Radiol Med. 2025 Aug 25. doi: 10.1007/s11547-025-02078-9.
2
MYCN as an oncogene in pediatric brain tumors.MYCN作为小儿脑肿瘤中的一种癌基因。
Front Oncol. 2025 Apr 29;15:1584978. doi: 10.3389/fonc.2025.1584978. eCollection 2025.
3
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome.

本文引用的文献

1
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).小儿脑桥组蛋白野生型伴MYCN扩增的胶质瘤（HGG-MYCN）的综合放射学、组织病理学和分子分析
Acta Neuropathol Commun. 2019 Jun 10;7(1):87. doi: 10.1186/s40478-019-0738-y.
2
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.脑外儿童高级别胶质瘤的分子病理影像学和免疫特征：HERBY 二期随机试验研究
Cancer Cell. 2018 May 14;33(5):829-842.e5. doi: 10.1016/j.ccell.2018.04.004.
3
伴有RB1和SETD2改变及李-弗劳梅尼综合征的儿童高级别胶质瘤
Acta Neuropathol Commun. 2025 Jan 16;13(1):8. doi: 10.1186/s40478-024-01885-x.
4
Emerging and Biological Concepts in Pediatric High-Grade Gliomas.儿童高级别胶质瘤的新兴和生物学概念。
Cells. 2024 Sep 5;13(17):1492. doi: 10.3390/cells13171492.
5
Cortically Based Brain Tumors in Children: A Decision-Tree Approach in the Radiology Reading Room.儿童皮质型脑肿瘤：放射科阅片中的决策树方法
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):11-23. doi: 10.3174/ajnr.A8477.
6
Molecular and Pathological Features of Paediatric High-Grade Gliomas.小儿高级别胶质瘤的分子和病理学特征。
Int J Mol Sci. 2024 Aug 3;25(15):8498. doi: 10.3390/ijms25158498.
7
Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?小儿中枢神经系统肿瘤与2021年世界卫生组织分类：肿瘤学家对病理学家有哪些需求？
Front Mol Neurosci. 2024 Mar 13;17:1268038. doi: 10.3389/fnmol.2024.1268038. eCollection 2024.
8
Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas.针对小儿高级别胶质瘤独特疾病格局的治疗靶点。
Front Oncol. 2024 Mar 8;14:1347694. doi: 10.3389/fonc.2024.1347694. eCollection 2024.
9
Updates on management of gliomas in the molecular age.分子时代胶质瘤管理的最新进展。
World J Clin Oncol. 2024 Feb 24;15(2):178-194. doi: 10.5306/wjco.v15.i2.178.
10
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.胶质瘤：连接肿瘤微环境、患者免疫特征与新型个性化免疫疗法
Front Immunol. 2024 Jan 11;14:1299064. doi: 10.3389/fimmu.2023.1299064. eCollection 2023.
H3 K27M-mutant diffuse midline gliomas in different anatomical locations.
不同解剖部位 H3 K27M 突变型弥漫中线胶质瘤。
Hum Pathol. 2018 Aug;78:89-96. doi: 10.1016/j.humpath.2018.04.015. Epub 2018 May 1.
4
H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.成人与儿童的H3 K27M突变型胶质瘤具有相似的组织学特征和不良预后。
Clin Neuropathol. 2018 Mar/Apr;37 (2018)(2):53-63. doi: 10.5414/NP301085.
5
H3 K27M mutations are extremely rare in posterior fossa group A ependymoma.H3 K27M突变在后颅窝A组室管膜瘤中极为罕见。
Childs Nerv Syst. 2017 Jul;33(7):1047-1051. doi: 10.1007/s00381-017-3481-3. Epub 2017 Jun 16.
6
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers.H3-/IDH-野生型儿童弥漫性脑胶质瘤由具有不同分子特征和预后的亚型组成，这些亚型与致癌驱动因子相关。
Acta Neuropathol. 2017 Sep;134(3):507-516. doi: 10.1007/s00401-017-1710-1. Epub 2017 Apr 11.
7
Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.双侧丘脑胶质瘤在分子水平上可能与其单侧高级别 counterparts 不同。
Brain Pathol. 2018 Jan;28(1):112-120. doi: 10.1111/bpa.12484. Epub 2017 Mar 12.
8
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.新的脑肿瘤实体源于中枢神经系统原始神经外胚层肿瘤的分子分类。
Cell. 2016 Feb 25;164(5):1060-1072. doi: 10.1016/j.cell.2016.01.015.
9
H3F3A K27M mutations in thalamic gliomas from young adult patients.丘脑胶质瘤中年轻成年患者的 H3F3A K27M 突变。
Neuro Oncol. 2014 Jan;16(1):140-6. doi: 10.1093/neuonc/not144. Epub 2013 Nov 26.
10
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.H3F3A 和 IDH1 热点突变定义了胶质母细胞瘤的独特表观遗传和生物学亚群。
Cancer Cell. 2012 Oct 16;22(4):425-37. doi: 10.1016/j.ccr.2012.08.024.